Európai Unió - cseh - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - imunopreparát pro felidae, - kočky - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Európai Unió - cseh - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - rekombinantní krůtí herpesvirus, napětí vhvt013-69, žít - imunopreparát pro aves, kur domácí, imunologické přípravky - embryonated eggs; chicken - pro aktivní imunizaci kuřat:k prevenci úhynu a ke zmírnění klinických příznaků a patologických změn infekční burzitidy drůbeže. ke snížení mortality, klinických příznaků a lézí markovy choroby.

Csehország - cseh - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

boehringer ingelheim animal health france scs - ptačí infekční burzitidě drůbeže virus vakcíny (nemoc gumboro) - Šumivá tableta pro suspenzi - Živé virové vakcíny - kur domácí, brojlerová kuřata, budoucí nosnice

Európai Unió - cseh - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - imunologická léčba - kuře - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Európai Unió - cseh - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kuře - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.